| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | Chief Financial Officer | Class B Common Stock, par value $0.0001 per share | 125K | $1.25M | $10.00 | Aug 5, 2021 | Direct |
| SelectQuote, Inc. | Director | Restricted Stock Units | 106K | Nov 11, 2025 | Direct | ||
| SelectQuote, Inc. | Director | No securities are beneficially owned. | 0 | Feb 28, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SLQT | SelectQuote, Inc. | Nov 11, 2025 | 1 | $0 | 4 | Nov 13, 2025 | Director |
| SLQT | SelectQuote, Inc. | Feb 28, 2025 | 1 | $0 | 4 | Mar 4, 2025 | Director |
| SLQT | SelectQuote, Inc. | Feb 28, 2025 | 0 | $0 | 3 | Mar 4, 2025 | Director |
| DALS | DA32 Life Science Tech Acquisition Corp. | Aug 5, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Chief Financial Officer |
| DALS | DA32 Life Science Tech Acquisition Corp. | Jul 27, 2021 | 0 | $0 | 3 | Jul 27, 2021 | Chief Financial Officer |